“I think as technology evolves, we as urologists need to continue to evolve and make changes to our practice,” says Kevin T. Keating, DO.
In this video, Matthew A. Rohloff, DO, and Kevin T. Keating, DO, discuss findings from the Urology Practice study, “Are Postoperative Laboratory Studies Following Robotic Assisted Radical Prostatectomy Necessary?” for which they served as study authors. Rohloff and Keating are urology residents at Metro Health – University of Michigan Health, Wyoming, Michigan.
Phase 1B trial to evaluate relugolix and enzalutamide in high-risk prostate cancer
July 24th 2024"Going forward after this study, we hope to be able to expand and potentially look at patients undergoing either surgery or radiation therapy, and really try to determine the potential benefit," says Kelly L. Stratton, MD, FACS.